DPHARMA

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2017

CCM DUOPHARMA BIOTECH BERHAD

Financial Year End 31 Dec 2017
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2017
The figures have not been audited
  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2017

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2017
30 Sep 2016
30 Sep 2017
30 Sep 2016
$$'000
$$'000
$$'000
$$'000
1 Revenue
115,379
80,302
355,734
238,907
2 Profit/(loss) before tax
14,207
7,516
38,971
25,180
3 Profit/(loss) for the period
11,127
6,226
30,332
17,995
4 Profit/(loss) attributable to ordinary equity holders of the parent
11,405
6,341
30,622
18,687
5 Basic earnings/(loss) per share (Subunit)
3.99
2.23
10.87
6.45
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.7000
1.6300

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name CCM DUOPHARMA BIOTECH BERHAD
Stock Name CCMDBIO
Date Announced 17 Nov 2017
Category Financial Results
Reference Number FRA-15112017-00027